| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |